Log in to save to my catalogue

Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer

Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3170568313

Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer

About this item

Full title

Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer

Publisher

Oxford: Oxford University Press

Journal title

JNCI cancer spectrum, 2022-09, Vol.6 (5)

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Estrogen receptor–positive breast tumors, which initially respond effectively to endocrine therapy, progress due to acquired endocrine therapy resistance, including genomic alterations in estrogen receptor alpha (ESR1). A recent study has suggested that there is a sufficient number of preexisting ESR1 mutations acting as an intrinsic resistance mec...

Alternative Titles

Full title

Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3170568313

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3170568313

Other Identifiers

ISSN

2515-5091

E-ISSN

2515-5091

DOI

10.1093/jncics/pkac060

How to access this item